Code No. | M101-3 | |
Anti-CD13 (Mouse) mAb | ||
Price | ¥30,800 | |
Size | 100 µL (1 mg/mL) | |
Availability (in Japan) | 1-9
(In Japan at 17:00, Feb 11, 2025 in JST) |
|
Clonality | Monoclonal | |
Clone | 123H1 | |
Isotype (Immunized Animal) |
Rat IgG2b | |
Applications | IP 5 µg/1000 µL of cell extract from 5x106 cells FCM 5-10 µg/mL (final concentration) |
|
Immunogen (Antigen) |
C57BL/6 mice-derived dendritic cells | |
Reactivity [Gene ID] | Mouse[16790] |
|
Storage buffer | 1 mg/mL in PBS/50% glycerol, pH 7.2 | |
Storage temp. | -20°C | |
Conjugate | Unlabeled | |
Manufacturer | MBL | |
Alternative names | Anpep, Apn, AP-M, AP-N, P150 | |
Background | CD13 is a myeloid differentiation molecule expressed on committed myeloid progenitors, granulocytes, monocytes, and leukemic cells of myeloid origin. It is also expressed on non-hematopoietic cells including fibroblasts, renal proximal tubule, and small intestine brush-border membrane. The gene for CD13 has recently been cloned the cDNA sequence shows that CD13 is the metalloprotease aminopeptidase N. Biochemical studies have shown that CD13 is a 150 kDa glycoprotein, which exists as a 130 kDa intracellular precursor form. This 130 kDa precursor molecule is posttranslationally modified in the Golgi apparatus to produce the 150 kDa mature cell surface form of the molecule. | |
Product category | Research area:Cell surface antigens | |
Data | ![]() |